pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Endocrinology & Metabolism · news · pharmadog
← back to Endocrinology & Metabolism
News · Endocrinology & Metabolism
432
stories
Aug 4, 26
Vertex’s biggest overhang: a rival 50 times smaller
biopharma dive
Aug 4, 26
Trans federal employees sue over revoked health coverage
stat
Aug 3, 26
Heart transplant candidates fail if they get too weak. New program tries inpatient prehab
stat
Jul 31, 26
Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
biospace
Jul 31, 26
‘It’s making a difference’: Madrigal CEO talks strategy behind MASH shopping spree
fiercebiotech
Jul 31, 26
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
fiercebiotech
Jul 30, 26
Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidance
fiercebiotech
Jul 30, 26
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
Jul 30, 26
GSK pens $110M biological datasets pact with AI biotech Relation
fiercebiotech
Jul 29, 26
Private biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergers
biospace
Jul 29, 26
AbCellera, Vertex partner on next-gen T-cell engagers
biopharma dive
Jul 28, 26
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
stat
Jul 28, 26
Eli Lilly tops new biopharma ranking on launch success, development speed
fiercebiotech
Jul 28, 26
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
biospace
Jul 28, 26
Anthony Fauci’s pandemic-era diary entries
stat
Jul 28, 26
Altimmune’s next-gen GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 alcohol use disorder win
fiercebiotech
Jul 28, 26
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
stat
Jul 27, 26
From confidence to capital: Positioning biotech for the next growth cycle
biopharma dive
Jul 27, 26
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
stat
Jul 27, 26
Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseases
fiercebiotech
Jul 23, 26
Updated: FDA adcomm backs popular wellness peptides, despite staff concerns
endpoints
Jul 23, 26
Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 data
biospace
Jul 23, 26
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
biospace
Jul 22, 26
Vertex was sole bidder in high-premium Crinetics acquisition
biopharma dive
Jul 22, 26
FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
fda press
Jul 22, 26
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
Jul 22, 26
From Big Pharma to specialty: why moving closer to the patient changes everything
biospace
Jul 21, 26
‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise
fiercebiotech
Jul 21, 26
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
biospace
Jul 21, 26
Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth
stat
← prev
page 9 of 15
next →